Diagnostics and Tools Blue Book August 2024

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• Exscientia was acquired by Recursion
• Getinge announced its acquisition of Paragonix
• Openwater closed a $100MM Series A Financing, led by Khosla Ventures, Plum Alley and Bold Capital Partners